When developing animals encounter nutrient restriction, most tissues stop growing. Some vital tissues, however, such as the brain, continue to grow. Now, Cheng et al. (2011) identify Alk as the kinase that allows the Drosophila brain to continue growing during nutrient restriction by bypassing the requirements for insulin receptor and TOR activation.
Not all animal tissues are created equal. Some enjoy preferential treatment if nutrients become limiting. This happens, for instance, in cases of intrauterine growth restriction in which fetuses experience inadequate nutrient and oxygen supply. In such cases, fetal blood circulation gets redistributed to preferentially perfuse the brain, in an attempt to maintain its oxygen supply (Roza et al., 2008) . This is one of potentially several mechanisms that lead to ''brain sparing,'' whereby babies are born smaller than normal but with proportionally large heads (Gruenwald, 1963) . Differential size scaling of the brain versus the rest of the body also occurs in response to genetic variation in the human population, wherein people of smaller stature have proportionally larger heads than people of larger stature (Koh et al., 2005) . Strikingly, analogous effects are observed in insects such as the fruit fly Drosophila, consistent with variable nutrient supply being an evolutionarily old problem. In cases of insufficient nutrients, flies grow smaller than normal but preferentially spare the most important tissues (Shingleton, 2010) . A study by Cheng et al. (2011) in this issue of Cell makes significant progress toward understanding how ''high-priority'' tissues maintain growth when nutrients become scarce.
Cheng et al. find that, analogously to humans, one organ that is strongly spared in the larva is the brain. When nutrients become restricted, larval brains continue to grow despite low levels of insulin peptides and low levels of amino acids in circulation. Since insulin and TOR signaling, which are normally activated by insulin and amino acids, respectively, are required in almost all tissues for growth, this was a surprising result.
Signaling through the insulin pathway is normally ''dominant'' to nutrient availability, in that tissues with low insulin signaling will not grow, even in the presence of nutrients (Bö hni et al., 1999) , whereas tissues with elevated insulin signaling will grow even in the absence of organismal nutrient availability (Britton et al., 2002) . Therefore, the mechanisms regulating tissue growth during nutrient restriction are likely to intersect with the insulin pathway, providing nutrient-insensitive One key signaling pathway regulating tissue growth is the insulin/TOR pathway. In most tissues except brain, activation of insulin receptor (InR) by insulin-like peptides, as well as activation of TOR by nutrient and growth factor signaling, are necessary for cells to grow. InR and TOR promote cell growth by regulating the activity of multiple downstream effectors, including phosphoinositide 3-kinase (PI3K), S6K, and 4E-BP. In the absence of nutrients, signaling through these pathways is turned off, blunting growth (rightside box). In contrast, in the brain, these downstream effectors are predominantly regulated by anaplastic lymphoma kinase (Alk). Alk is activated in a nutrient-independent manner via its ligand Jelly belly, which is expressed by neighboring glia. This allows brain tissue to grow also in the absence of InR and TOR activation and, hence, in the absence of nutrients (left-hand box).
inputs to activate key components of the pathway. Cheng et al. thus proceeded to carefully test which components of the insulin and TOR pathways are required for brain growth. TOR regulates cell mass accumulation in part via two well-described effector targets that control translation, S6K and 4E-BP. Surprisingly, the authors found that removing S6K or 4E-BP did indeed have profound effects on brain growth. In contrast, removing TOR did not. This poses a conundrum, in that removing the upstream kinase, TOR, does not affect brain growth, whereas removing its effectors does! Likewise, Gould et al. found that removing the insulin receptor (InR) had no effect on brain growth, whereas removing its downstream effector kinases, PI3K, Pdk1, and Akt/PKB, did.
The authors solved this mystery by postulating that another kinase must be taking over the jobs of InR and TOR in the brain, activating their downstream targets. Indeed, by screening for kinases that are required for brain growth, they identified the postulated kinase to be anaplastic lymphoma kinase (Alk). They found that Alk in the brain is able to induce phosphorylation of the effector targets of InR and TOR. Because the activating ligand of Alk, Jelly belly, is expressed by glia in a nutrient-independent manner, this allows the brain to maintain growth during nutrient restriction (Figure 1 ). The authors go on to show that Alk overexpression is sufficient to confer nutrient-dependent growth to the salivary gland, a tissue whose growth is normally limited during nutrient restriction. One open question warranting further investigation is how Alk is able to activate the targets of InR and TOR.
One key concept that emerges from this study is that the connectivity architecture of signaling pathways is not static in space and time. Instead, it gets rewired depending on the tissue type and on inputs from other signaling pathways. For a tissue to grow during nutrient restriction, it needs to activate key components of the insulin and TOR pathway in a nutrient-independent manner. Chen et al. show that, in the brain, this occurs via Alk. Analogously, tissue growth continues throughout pupal stages, when animals have stopped eating, due to nutrient-independent expression of an insulin-like peptide ILP6, thereby activating the insulin pathway in a nutrient-independent manner (Okamoto et al., 2009; Slaidina et al., 2009) . Finally, when larvae are deprived of amino acids, their imaginal discs can continue growing, and this appears to be mediated via inputs from ecdysone signaling (Mirth et al., 2009) .
These findings are also particularly intriguing from the cancer perspective. Due to their capacities to drive tissue growth, both insulin and TOR signaling are potent oncogenic pathways. The finding that Alk can replace InR and TOR in the central nervous system might explain why Alk is frequently mutated in neuroblastoma (Ogawa et al., 2011) .
